AS

Amy Sinor-Anderson

Senior Director Of Medical Communications at GRAIL

Amy Sinor-Anderson's work experience includes:

- Senior Director of Medical Communications at GRAIL, Inc. since February 2022. Previously, they were the Director of Medical Communications from August 2020 to January 2022.

- Associate Director of Medical Communications and Publications at EMD Serono, Inc. from January 2017 to July 2020. In this role, they led the launch readiness of cladribine tablets and developed scientific communications platforms for neurology and immunology. Amy also directed medical communications strategies at congresses and facilitated relationships with healthcare professionals.

- Senior Medical Science Liaison and Medical Science Liaison at EMD Serono, Inc. from January 2017 to June 2017 and from November 2014 to December 2016, respectively. As a medical science liaison, they provided support to healthcare professionals, gathered competitive and scientific knowledge, and established relationships for advisory boards and steering committees.

- Senior Research Scientist and Team Leader at GE Healthcare from March 2014 to November 2014. Amy oversaw feasibility and product development projects in neuroscience and stem cell fields, managed timelines and budgets, and fostered collaborations.

- Senior Research Scientist at Thermo Fisher Scientific from October 2010 to March 2014. In this role, they led new product development projects, designed and implemented cellular assays, and contributed to pre and post-product launch materials.

- Scientist - Assay Development/High Content Imaging at Harvard Stem Cell Institute - Harvard University from December 2006 to October 2010. Amy led motor neuron assay development for neurodegenerative disease therapeutics and assisted in grant acquisition.

- Scientist II, Scientist I, and Researcher at Curis from December 2005 to December 2006, January 2005 to December 2005, and June 2004 to December 2004, respectively. In these roles, they established survival assays, optimized algorithms for data analysis, and identified hits from small-molecule libraries.

Amy Sinor-Anderson holds a Bachelor of Arts (BA) degree in Biology and Chemistry from Skidmore College. Amy then pursued their education further at the University of Pittsburgh School of Medicine, where they obtained a PhD in Neurobiology.

Links

Timeline

  • Senior Director Of Medical Communications

    February, 2022 - present

  • Director Of Medical Communications

    August, 2020

View in org chart